Humana shares are trading lower after Stephens & Co maintained an Overweight rating on the stock but lowered its price target from $575 to $570.
Portfolio Pulse from Benzinga Newsdesk
Humana's stock price is trading lower after Stephens & Co maintained an Overweight rating but lowered its price target from $575 to $570.
November 02, 2023 | 5:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana's stock price is expected to be negatively impacted in the short term due to the lowered price target by Stephens & Co.
Stephens & Co, a significant market analyst, has lowered its price target for Humana from $575 to $570. This indicates a less optimistic outlook for the company's stock, which can lead to a decrease in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100